ACTIFED SYRUP 1.25 MG / 5 ML
TRIPROLIDINE HYDROCHLORIDE : 1.25 MG / 5 ML PSEUDOEPHEDRINE HYDROCHLORIDE : 30 MG / 5 ML · DIN 00068497 · GLAXO WELLCOME INC.
Health Canada status: CANCELLED POST MARKET
What is ACTIFED SYRUP?
ACTIFED SYRUP 1.25 MG / 5 ML contains TRIPROLIDINE HYDROCHLORIDE : 1.25 MG / 5 ML PSEUDOEPHEDRINE HYDROCHLORIDE : 30 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 00068497, held by GLAXO WELLCOME INC., supplied as LIQUID for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 03-Aug-2000. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00068497 |
|---|---|
| Brand name | ACTIFED SYRUP |
| Generic / active ingredient | TRIPROLIDINE HYDROCHLORIDE : 1.25 MG / 5 ML PSEUDOEPHEDRINE HYDROCHLORIDE : 30 MG / 5 ML |
| Manufacturer | GLAXO WELLCOME INC. |
| Strength | 1.25 MG / 5 ML |
| Dosage form | LIQUID |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R01BA52 PSEUDOEPHEDRINE, COMBINATIONS |
| AHFS class | 12:12.12 ; 04:04.20 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 03-Aug-2000 |
| Original market date | 1960-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code R01BA52 PSEUDOEPHEDRINE, COMBINATIONS. 5 of 30 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AERIUS SINUS + ALLERGY | 120 MG | TABLET (EXTENDED-RELEASE) | BAYER INC | MARKETED | DIN 02309300 |
| ALLEGRA-D | 60 MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | SANOFI CONSUMER HEALTH INC | MARKETED | DIN 02239853 |
| CLARITIN ALLERGY + SINUS | 5 MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | BAYER INC | MARKETED | DIN 01945157 |
| CLARITIN ALLERGY + SINUS EXTRA STRENGTH | 10 MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | BAYER INC | MARKETED | DIN 02260557 |
| REACTINE COMPLETE | 120 MG | TABLET (EXTENDED-RELEASE) | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02246162 |
| ACTIFED TABLETS | 2.5 MG | TABLET | GLAXO WELLCOME INC. | CANCELLED POST MARKET | DIN 00068500 |
| ACTIFED TABLETS | 60 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED POST MARKET | DIN 02238302 |
| AERIUS DUAL ACTION 24 HOUR | 240 MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | BAYER INC | CANCELLED PRE MARKET | DIN 02377195 |
| BENADRYL DECONGESTANT TABLETS | 25 MG | TABLET | WARNER-LAMBERT CANADA INC. | CANCELLED POST MARKET | DIN 02019728 |
| BENYLIN D-AH FOR CHILDREN | 1 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED PRE MARKET | DIN 02248334 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.